Conformational transitions of islet amyloid polypeptide (IAPP) in amyloid formation in vitro.

No abstract is available for this paper.

• Publication year

  1999

• Venue

  Journal of Molecular Biology

• Publication date

  1999-04-09

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1006/JMBI.1999.2646PMID 10191146
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Group additive contributions to the alcohol-induced alpha-helix formation of melittin: implication for the mechanism of the alcohol effects on proteins.

  1998cited by this paper
• Contribution of advanced glycosylation to the amyloidogenicity of islet amyloid polypeptide.

  1998cited by this paper
• Amyloid fibril formation by an SH3 domain.

  1998cited by this paper
• Formation of amyloid-like fibrils by self-association of a partially unfolded fibronectin type III module.

  1998cited by this paper
• Models of amyloid seeding in Alzheimer's disease and scrapie: mechanistic truths and physiological consequences of the time-dependent solubility of amyloid proteins.

  1997cited by this paper
• Polymorphic fibrillar assembly of human amylin.

  1997cited by this paper
• Acceleration of the folding of hen lysozyme by trifluoroethanol.

  1997cited by this paper
• Instability, unfolding and aggregation of human lysozyme variants underlying amyloid fibrillogenesis

  1997cited by this paper
• pH-dependent Stability and Conformation of the Recombinant Human Prion Protein PrP(90–231)*

  1997cited by this paper
• Atomic force microscopic imaging of seeded fibril formation and fibril branching by the Alzheimer's disease amyloid-beta protein.

  1997cited by this paper
• Native-like β-structure in a Trifluoroethanol-induced Partially Folded State of the All-β-sheet Protein Tendamistat

  1996cited by this paper
• Circular Dichroism and the Conformational Analysis of Biomolecules

  1996cited by this paper
• Methods to estimate the conformation of proteins and polypeptides from circular dichroism data.

  1996cited by this paper
• Aromatic and Cystine Side-Chain Circular Dichroism in Proteins

  1996cited by this paper
• The β Sheet ⇌ Coil Transition of Polypeptides, as Determined by Circular Dichroism

  1996cited by this paper
• First-order kinetic model of Alzheimer's beta-amyloid fibril extension in vitro.

  1996cited by this paper
• Physical, morphological and functional differences between ph 5.8 and 7.4 aggregates of the Alzheimer's amyloid peptide Abeta.

  1996cited by this paper
• Native-like beta-structure in a trifluoroethanol-induced partially folded state of the all-beta-sheet protein tendamistat.

  1996cited by this paper
• The acid-mediated denaturation pathway of transthyretin yields a conformational intermediate that can self-assemble into amyloid.

  1996cited by this paper
• Two conformational states of amyloid β-peptide: implications for the pathogenesis of Alzheimer's disease

  1995cited by this paper
• Toward understanding amyloid aggregation.

  1995cited by this paper
• Molten globule and protein folding.

  1995cited by this paper
• Solvent effects on self-assembly of beta-amyloid peptide.

  1995cited by this paper
• The chemistry of scrapie infection: implications of the 'ice 9' metaphor.

  1995cited by this paper
• Effect of pH and insulin on fibrillogenesis of islet amyloid polypeptide in vitro.

  1995cited by this paper
• Defective protein folding as a basis of human disease.

  1995cited by this paper
• Rotational Resonance Solid-State NMR Elucidates a Structural Model of Pancreatic Amyloid

  1995cited by this paper
• Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red.

  1994cited by this paper
• Pancreatic islet cell toxicity of amylin associated with type-2 diabetes mellitus

  1994cited by this paper
• Scrapie amyloid (prion) protein has the conformational characteristics of an aggregated molten globule folding intermediate.

  1994cited by this paper
• Reversible random coil-beta-sheet transition of the Alzheimer beta-amyloid fragment (25-35).

  1994cited by this paper
• Beta-structure in human amylin and two designer beta-peptides: CD and NMR spectroscopic comparisons suggest soluble beta-oligomers and the absence of significant populations of beta-strand dimers.

  1994cited by this paper
• β-Structure in Human Amylin and 2 Designer β-Peptides: CD and NMR Spectroscopic Comparisons Suggest Soluble β-Oligomers and the Absence of Significant Populations of β-Strand Dimers

  1994cited by this paper
• Peptide Models of a Hydrophobic Cluster at the C-Terminus of the Beta-Amyloid Protein

  1994cited by this paper
• Amyloidosis.

  1994cited by this paper
• Interspecies sequence variations affect the kinetics and thermodynamics of amyloid formation : peptide models of pancreatic amyloid

  1993cited by this paper
• A kinetic model for amyloid formation in the prion diseases: importance of seeding.

  1993cited by this paper
• Conversion of alpha-helices into beta-sheets features in the formation of the scrapie prion proteins.

  1993cited by this paper
• Seeding "one-dimensional crystallization" of amyloid: a pathogenic mechanism in Alzheimer's disease and scrapie?

  1993cited by this paper
• Aggregation of globular proteins

  1993cited by this paper
• Aggregation and denaturation of apomyoglobin in aqueous urea solutions.

  1993cited by this paper
• The structural basis of pancreatic amyloid formation : isotope-edited spectroscopy in the solid state

  1992cited by this paper
• In pursuit of the molecular structure of amyloid plaque: new technology provides unexpected and critical information.

  1992cited by this paper
• Analysis of the circular dichroism spectrum of proteins using the convex constraint algorithm: a practical guide.

  1992cited by this paper
• Aggregation and secondary structure of synthetic amyloid βA4 peptides of Alzheimer's disease

  1991cited by this paper
• Temperature of polypeptide inverse temperature transition depends on mean residue hydrophobicity

  1991cited by this paper
• Aggregation and secondary structure of synthetic amyloid beta A4 peptides of Alzheimer's disease.

  1991cited by this paper
• In vitro aging of beta-amyloid protein causes peptide aggregation and neurotoxicity.

  1991cited by this paper
• In vitro aging of ß-amyloid protein causes peptide aggregation and neurotoxicity ☆

  1991cited by this paper
• Solution structures of beta peptide and its constituent fragments: relation to amyloid deposition.

  1991cited by this paper
• Molecular model-building of amylin and alpha-calcitonin gene-related polypeptide hormones using a combination of knowledge sources.

  1991cited by this paper
• Study of the “molten globule” intermediate state in protein folding by a hydrophobic fluorescent probe

  1991cited by this paper
• Intermediates in the folding reactions of small proteins.

  1990cited by this paper
• Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation.

  1990cited by this paper
• The molten globule state as a clue for understanding the folding and cooperativity of globular‐protein structure

  1989cited by this paper
• Amylin found in amyloid deposits in human type 2 diabetes mellitus may be a hormone that regulates glycogen metabolism in skeletal muscle.

  1988cited by this paper
• Purification and characterization of a peptide from amyloid-rich pancreases of type 2 diabetic patients.

  1987cited by this paper
• Amyloid fibrils in human insulinoma and islets of Langerhans of the diabetic cat are derived from a neuropeptide-like protein also present in normal islet cells.

  1987cited by this paper
• Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes.

  1987cited by this paper
• Irreversible Nature of the Stacked β-Pleated Sheets of a Model Polypeptide

  1987cited by this paper
• [12]Refolding and association of oligomeric proteins

  1986cited by this paper
• Refolding and association of oligomeric proteins.

  1986cited by this paper
• Calculation of protein conformation from circular dichroism.

  1986cited by this paper
• Characterization of an associated equilibrium folding intermediate of bovine growth hormone.

  1986cited by this paper
• Reversible and irreversible conversion between the intermolecular beta-structure and the disordered state of poly(S-carboxymethyl-L-cysteine) in aqueous media.

  1982cited by this paper
• Isodichroic point and the β–random coil transition of poly(S‐carboxymethyl‐L‐cysteine) and poly(S‐carboxyethyl‐L‐cysteine) in the absence of added salt

  1981cited by this paper
• Determination of protein secondary structure in solution by vacuum ultraviolet circular dichroism.

  1980cited by this paper
• The interaction of a naphthalene dye with apomyoglobin and apohemoglobin. A fluorescent probe of non-polar binding sites.

  1965cited by this paper

• Decoding the Relationship between Alzheimer's Disease and Type-2 Diabetes via the Protein Aggregation Prism.

  2025cites this paper
• Synthetic deformylated α-helical PSMα3 as a selective inhibitor of human amyloid aggregation

  2025cites this paper
• Inhibitory mechanism of lithospermic acid on the fibrillation of type 2 diabetes associated islet amyloid polypeptide.

  2025cites this paper
• Deciphering the impact of F23L mutation on the aggregation propensity of human islet amyloid polypeptide using molecular simulations

  2024cites this paper
• Unveiling molecular mechanism underlying inhibition of human islet amyloid polypeptide fibrillation by benzene carboxylic acid-peptide conjugate

  2024cites this paper
• Delineating the impact of N21D mutation on the conformational preferences and structural transitions in human islet amyloid polypeptide

  2024cites this paper
• Natural compound plumbagin based inhibition of hIAPP revealed by Markov state models based on MD data along with experimental validations

  2024influential citation
• Understanding the structural dynamics of human islet amyloid polypeptide: Advancements in and applications of ion-mobility mass spectrometry.

  2024cites this paper
• Broken but not beaten: Challenge of reducing the amyloids pathogenicity by degradation

  2024cites this paper
• A human antibody against pathologic IAPP aggregates protects beta cells in type 2 diabetes models

  2023cites this paper
• TPE conjugated islet amyloid polypeptide probe for detection of peptide oligomers.

  2023cites this paper
• Molecular Insights into the Self-Assembly of a Full-Length hIAPP Trimer: β-Protofibril Formed by β-Hairpin Lateral or Longitudinal Association.

  2023cites this paper
• In silico design and identification of new peptides for mitigating hIAPP aggregation in type 2 diabetes

  2023cites this paper
• In silico studies of the human IAPP in the presence of osmolytes

  2022cites this paper
• Human islet amyloid polypeptide: A therapeutic target for the management of type 2 diabetes mellitus

  2022cites this paper
• Designed peptides as nanomolar cross-amyloid inhibitors acting via supramolecular nanofiber co-assembly

  2022cites this paper
• Understanding the mechanism of amylin aggregation: From identifying crucial segments to tracing dominant sequential events to modeling potential aggregation suppressors.

  2022cites this paper
• Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

  2022cites this paper
• Aromatic interactions directing peptide nano-assembly.

  2022cites this paper
• Linking hIAPP misfolding and aggregation with type 2 diabetes mellitus: a structural perspective

  2022cites this paper
• Linking Alzheimer’s Disease and Type 2 Diabetes: Characterization and Inhibition of Cytotoxic Aβ and IAPP Hetero-Aggregates

  2022cites this paper
• Tuning the rate of aggregation of hIAPP into amyloid using small-molecule modulators of assembly

  2022cites this paper
• Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies.

  2021cites this paper
• Easy Production of "Difficult Peptides" using Cell-Free Protein Synthesis and a New Methionine Analogue as a Latent Peptide Cleavage Site.

  2021cites this paper
• Surface-Catalyzed Secondary Nucleation Dominates the Generation of Toxic IAPP Aggregates

  2021cites this paper
• Nonhuman IAPP Variants Inhibit Human IAPP Aggregation.

  2021cites this paper
• Nanoscale Surface Topography Modulates hIAPP Aggregation Pathways at Solid–Liquid Interfaces

  2021cites this paper
• Serotonin and Melatonin Show Different Modes of Action on Aβ42 Protofibril Destabilization.

  2021cites this paper
• Pristine and Hydroxylated Fullerenes Prevent the Aggregation of Human Islet Amyloid Polypeptide and Display Different Inhibitory Mechanisms

  2020cites this paper
• Prebiotic Peptides: Molecular Hubs in the Origin of Life.

  2020cites this paper
• Molecular Insight into the Effects of Enhanced Hydrophobicity on Amyloid-like Aggregation.

  2020cites this paper
• Molecular mechanisms of amyloid aggregation in human proteinopathies

  2020cites this paper
• The Human Host‐Defense Peptide Cathelicidin LL‐37 is a Nanomolar Inhibitor of Amyloid Self‐Assembly of Islet Amyloid Polypeptide (IAPP)

  2020cites this paper
• Formation of α-synuclein aggregates in aqueous ethylammonium nitrate solutions.

  2020cites this paper
• Functional amyloids

  2020cites this paper
• Introduction and Fundamentals of Human Islet Amyloid Polypeptide Inhibitors.

  2020cites this paper
• Human islet amyloid polypeptide (hIAPP) - a curse in type II diabetes mellitus: insights from structure and toxicity studies

  2020cites this paper
• Efficacy and mechanism of action of long-term treatment with antibody NI-203.26C11 targeting aggregated IAPP in type 2 diabetes

  2020cites this paper
• Fast screening method for molecular recognition of islet amyloid polypeptide from whole blood samples collected from diabetic patients with disposable stochastic sensors obtained by nanolayer, and nanolayer by nanolayer deposition using cold plasma

  2020cites this paper
• Das humane Wirtsabwehrpeptid Cathelicidin LL‐37 ist ein nanomolarer Inhibitor der amyloiden Selbstassoziation von Inselamyloid‐Polypeptid (IAPP)

  2020cites this paper
• Representation of the conformational ensemble of peptides in coarse grained simulations.

  2020cites this paper
• Effects of in vivo conditions on amyloid aggregation.

  2019cites this paper
• Assembly behavior of amylin fragment hIAPP19-37 regulated by Au(III) complexes.

  2019cites this paper
• Molecular dynamics simulation study on the inhibitory effects of choline‐O‐sulfate on hIAPP protofibrilation

  2019cites this paper
• Effects of lithospermic acid on hIAPP aggregation and amyloid-induced cytotoxicity by multiple analytical methods.

  2019cites this paper
• Blocking inflammasome activation caused by β-amyloid peptide (Aβ) and islet amyloid polypeptide (IAPP) through an IAPP mimic.

  2019cites this paper
• The pressure and temperature perturbation approach reveals a whole variety of conformational substates of amyloidogenic hIAPP monitored by 2D NMR spectroscopy.

  2019cites this paper
• Simulation Studies of Amyloidogenic Polypeptides and Their Aggregates.

  2019cites this paper
• Norepinephrine Inhibits Alzheimer's Amyloid-β Peptide Aggregation and Destabilizes Amyloid-β Protofibrils: A Molecular Dynamics Simulation Study.

  2019cites this paper
• Pre-structured hydrophobic peptide β-strands: A universal amyloid trap?

  2019cites this paper
• Life in Phases: Intra- and Inter- Molecular Phase Transitions in Protein Solutions

  2019cites this paper
• Nitration of hIAPP promotes its toxic oligomer formation and exacerbates its toxicity towards INS-1 cells.

  2019cites this paper
• Molecular mechanics and quantum chemical calculations unveil the combating effect of baicalein on human islet amyloid polypeptide aggregates

  2019cites this paper
• The mechanism of phosphatidylcholine‐induced interference of PAP (248‐286) aggregation

  2019cites this paper
• A Novel Pentapeptide Inhibitor Reduces Amyloid Deposit Formation by Direct Interaction with hIAPP

  2019cites this paper
• Inhibitory effects of oxidovanadium complexes on the aggregation of human islet amyloid polypeptide and its fragments.

  2019cites this paper
• Molecular Dynamics Simulations Reveal the Inhibitory Mechanism of Dopamine against hIAPP Aggregation and its Destabilization effect on hIAPP Protofibrils.

  2019cites this paper
• Influence of fullerenol on hIAPP aggregation: amyloid inhibition and mechanistic aspects.

  2019cites this paper
• Aggregation-induced conformation changes dictate islet amyloid polypeptide (IAPP) membrane affinity.

  2018cites this paper
• IAPP/amylin and β-cell failure: implication of the risk factors of type 2 diabetes

  2018cites this paper
• Detection and characterization at nM concentration of oligomers formed by hIAPP, Aβ(1-40) and their equimolar mixture using SERS and MD simulations.

  2018cites this paper
• IAPP Amyloid Aggregation and IAPP-Associated Toxicity Mitigation

  2018cites this paper
• Exploring the relation between the oligomeric structure and membrane damage by a study on rat islet amyloid polypeptide.

  2018cites this paper
• On the Applicability of Force Fields To Study the Aggregation of Amyloidogenic Peptides Using Molecular Dynamics Simulations.

  2018cites this paper
• Structural Modulation of Human Amylin Protofilaments by Naturally Occurring Mutations.

  2018cites this paper
• Islet Amyloid Polypeptide Promotes Amyloid-Beta Aggregation by Binding-Induced Helix-Unfolding of the Amyloidogenic Core.

  2018cites this paper
• Kinetic and Conformational Insights into Islet Amyloid Polypeptide Self-Assembly Using a Biarsenical Fluorogenic Probe.

  2018cites this paper
• The Molecular Physiopathogenesis of Islet Amyloidosis.

  2018cites this paper
• Membranes as modulators of amyloid protein misfolding and target of toxicity.

  2018cites this paper
• NFGAIL Amyloid Oligomers: The Onset of Beta-Sheet Formation and the Mechanism for Fibril Formation.

  2018cites this paper
• De Novo Designed α-Sheet Peptides Inhibit Functional Amyloid Formation of Streptococcus mutans Biofilms.

  2018cites this paper
• Membrane-mediated amyloid deposition of human islet amyloid polypeptide

  2018cites this paper
• Analysis of multiply charged monomers and dimers of human islet amyloid polypeptide by collision-induced dissociation with electrospray ionization mass spectrometry

  2018cites this paper
• A Free Energy Barrier Caused by the Refolding of an Oligomeric Intermediate Controls the Lag Time of Amyloid Formation by hIAPP.

  2017cites this paper
• Clinical Implications of Osmolytes in Various Human Diseases

  2017cites this paper
• The redox environment triggers conformational changes and aggregation of hIAPP in Type II Diabetes

  2017influential citation
• Orcein-Related Small Molecule O4 Destabilizes hIAPP Protofibrils by Interacting Mostly with the Amyloidogenic Core Region.

  2017cites this paper
• Formation of functional, non-amyloidogenic fibres by recombinant Bacillus subtilis TasA

  2017cites this paper
• Inhibition of Human Amylin Amyloidogenesis by Human Amylin-Fragment Peptides: Exploring the Effects of Serine Residues and Oligomerization upon Inhibitory Potency.

  2017cites this paper
• Seed-Induced Heterogeneous Cross-Seeding Self-Assembly of Human and Rat Islet Polypeptides

  2017cites this paper
• Formation of functional, non‐amyloidogenic fibres by recombinant Bacillus subtilis TasA

  2017cites this paper
• Recombinant human islet amyloid polypeptide forms shorter fibrils and mediates β-cell apoptosis via generation of oxidative stress.

  2017cites this paper
• Key aromatic/hydrophobic amino acids controlling a cross-amyloid peptide interaction versus amyloid self-assembly

  2017influential citation
• Molecular dynamics simulation on the inhibition mechanism of peptide‐based inhibitor of islet amyloid polypeptide (IAPP) to islet amyloid polypeptide (IAPP22–28) oligomers

  2017cites this paper
• Interaction of nonionic detergents with the specific sites of lysozyme amyloidogenic region - inhibition of amyloid fibrillization.

  2017cites this paper
• Human Islet Amyloid Polypeptide N-Terminus Fragment Self-Assembly: Effect of Conserved Disulfide Bond on Aggregation Propensity

  2016cites this paper
• The removal of disulfide bonds in amylin oligomers leads to the conformational change of the 'native' amylin oligomers.

  2016cites this paper
• The Role of Cholesterol in Driving IAPP-Membrane Interactions.

  2016cites this paper
• Human Islet Amyloid Polypeptide Assembly: The Key Role of the 8-20 Fragment.

  2016cites this paper
• An Account of Amyloid Oligomers: Facts and Figures Obtained from Experiments and Simulations

  2016cites this paper
• Protein aggregation and neurodegenerative diseases: From theory to therapy.

  2016cites this paper
• Conformational Ensemble of hIAPP Dimer: Insight into the Molecular Mechanism by which a Green Tea Extract inhibits hIAPP Aggregation

  2016cites this paper
• Insights into the Conformational Ensemble of Human Islet Amyloid Polypeptide from Molecular Simulations.

  2016cites this paper
• Southeast Europe Journal of Soft Available online:

  2016cites this paper
• Caractérisation du rôle de l’amyline (IAPP) dans le diabète de type 2 : études de dérivés peptidiques et de composés inhibiteurs de la formation d’amyloïde

  2016cites this paper
• Molecular interaction between type 2 diabetes and Alzheimer’s disease through cross-seeding of protein misfolding

  2016cites this paper
• Effect of Post-Translational Amidation on Islet Amyloid Polypeptide Conformational Ensemble: Implications for Its Aggregation Early Steps

  2016cites this paper
• Controlling the Physical Dimensions of Peptide Nanotubes by Supramolecular Polymer Coassembly.

  2016cites this paper
• Inhibition of hIAPP Amyloid Aggregation and Pancreatic β-Cell Toxicity by OH-Terminated PAMAM Dendrimer.

  2016cites this paper
• Conformational Substates of Amyloidogenic hIAPP Revealed by High Pressure NMR Spectroscopy

  2016cites this paper